ACSL5

acyl-CoA synthetase long chain family member 5, the group of Acyl-CoA synthetase family

Basic information

Region (hg38): 10:112374116-112428379

Previous symbols: [ "FACL5" ]

Links

ENSG00000197142NCBI:51703OMIM:605677HGNC:16526Uniprot:Q9ULC5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • diarrhea 13 (Limited), mode of inheritance: Unknown

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ACSL5 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACSL5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
clinvar
2
missense
30
clinvar
2
clinvar
2
clinvar
34
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 30 3 4

Variants in ACSL5

This is a list of pathogenic ClinVar variants found in the ACSL5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-112376317-C-T not specified Likely benign (Sep 14, 2022)2311963
10-112376319-C-G not specified Uncertain significance (Mar 29, 2023)2538279
10-112376345-C-A not specified Uncertain significance (Dec 13, 2023)3140072
10-112376369-G-C not specified Uncertain significance (Jun 27, 2022)2297839
10-112376374-C-T not specified Likely benign (Aug 08, 2022)2407314
10-112394984-C-T not specified Uncertain significance (Nov 03, 2023)3140059
10-112395065-C-A Benign (May 09, 2018)707869
10-112395079-A-G not specified Uncertain significance (Sep 06, 2022)2310292
10-112398947-G-C not specified Uncertain significance (Mar 14, 2023)2496107
10-112404540-C-A not specified Uncertain significance (May 18, 2023)2507514
10-112404741-T-G not specified Uncertain significance (Sep 06, 2022)2310120
10-112408412-C-T Benign (Jun 12, 2018)784168
10-112408450-C-T not specified Uncertain significance (Oct 12, 2021)2254116
10-112408455-T-A not specified Uncertain significance (Dec 02, 2021)2263120
10-112408495-A-C not specified Uncertain significance (Dec 14, 2023)3140097
10-112409515-G-A not specified Uncertain significance (May 11, 2022)2343054
10-112409525-T-C not specified Uncertain significance (Aug 17, 2021)2246263
10-112409597-T-A not specified Uncertain significance (Oct 14, 2023)3140105
10-112409682-T-A Likely benign (Feb 01, 2024)3024818
10-112410592-C-G not specified Uncertain significance (Jun 07, 2023)2524677
10-112411915-C-T not specified Uncertain significance (Oct 05, 2023)3140011
10-112411920-C-G not specified Uncertain significance (Dec 27, 2022)2339460
10-112413242-A-T not specified Uncertain significance (May 07, 2024)3262935
10-112416919-A-G not specified Uncertain significance (Jun 16, 2024)3262969
10-112416935-G-A Benign (May 09, 2018)784211

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ACSL5protein_codingprotein_codingENST00000356116 2154363
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.89e-90.9991257030451257480.000179
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7173694100.9000.00002124841
Missense in Polyphen129161.080.800821941
Synonymous0.9601441590.9030.000009031411
Loss of Function2.962141.60.5050.00000191517

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005110.000511
Ashkenazi Jewish0.000.00
East Asian0.0003260.000326
Finnish0.0001390.000139
European (Non-Finnish)0.0001670.000167
Middle Eastern0.0003260.000326
South Asian0.0001310.000131
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acyl-CoA synthetases (ACSL) activate long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. ACSL5 may activate fatty acids from exogenous sources for the synthesis of triacylglycerol destined for intracellular storage (By similarity). Utilizes a wide range of saturated fatty acids with a preference for C16-C18 unsaturated fatty acids (By similarity). It was suggested that it may also stimulate fatty acid oxidation (By similarity). At the villus tip of the crypt-villus axis of the small intestine may sensitize epithelial cells to apoptosis specifically triggered by the death ligand TRAIL. May have a role in the survival of glioma cells. {ECO:0000250, ECO:0000269|PubMed:17681178, ECO:0000269|PubMed:18806831, ECO:0000269|PubMed:19459852}.;
Pathway
Adipocytokine signaling pathway - Homo sapiens (human);Peroxisome - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);Fatty acid biosynthesis - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Ferroptosis - Homo sapiens (human);Fatty Acid Beta Oxidation;Fatty Acid Biosynthesis;PPAR signaling pathway;Liver steatosis AOP;stearate biosynthesis;Metabolism of lipids;Fatty acyl-CoA biosynthesis;fatty acid activation;Leukotriene metabolism;Omega-3 fatty acid metabolism;Metabolism;Fatty acid metabolism;γ-linolenate biosynthesis;Mono-unsaturated fatty acid beta-oxidation;Omega-6 fatty acid metabolism;Di-unsaturated fatty acid beta-oxidation;Phytanic acid peroxisomal oxidation;fatty acid β-oxidation (peroxisome);icosapentaenoate biosynthesis II (metazoa);fatty acid β-oxidation;Synthesis of very long-chain fatty acyl-CoAs (Consensus)

Recessive Scores

pRec
0.157

Intolerance Scores

loftool
0.837
rvis_EVS
0.27
rvis_percentile_EVS
70.64

Haploinsufficiency Scores

pHI
0.146
hipred
N
hipred_score
0.499
ghis
0.426

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.791

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Acsl5
Phenotype
skeleton phenotype; vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype;

Gene ontology

Biological process
long-chain fatty acid metabolic process;long-chain fatty-acyl-CoA biosynthetic process
Cellular component
nucleus;nucleolus;mitochondrion;mitochondrial outer membrane;endoplasmic reticulum membrane;membrane;integral component of membrane
Molecular function
long-chain fatty acid-CoA ligase activity;ATP binding;decanoate-CoA ligase activity